VINCENT FASANELLO: Open Payments
NPI 1902827314 · PITTSFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 70 payments from 5 companies in 2025. Trend: 2023 $205 · 2024 $165 · 2025 $1,157
Food & beverage: $1,157
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $556 |
| Lundbeck LLC | 7 | $187 |
| ABBVIE INC. | 19 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $152 |
| Axsome Therapeutics, Inc. | 5 | $88 |
Products named: CAPLYTA, REXULTI, VRAYLAR, TRINTELLIX, Auvelity.
Industry payments across NY — which companies pay providers there.
